{"cdcTestId":"2013-0488","testcaseName":"#2 @ 16 yr - 4 days, MCV4","vaccineGroup":"MCV","evaluationTestType":"Age: At Absolute Minimum","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2006-10-23T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2017-10-23T00:00:00","vaccineName":"MENACTRA","cvx":"114","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"MENACTRA","cvx":"114","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2017-10-23T00:00:00","vaccineName":"MENACTRA","cvx":"114","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"MENACTRA","cvx":"114","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-01T09:53:37.143","generalDescription":"This test case describes when dose #2 of a Mening vaccine is given at 16 years - 4 days, that the dose is considered valid.  The series is complete. ","changedInVersion":"1.6","reasonForChange":"v1.6: Updated Test case to reflect new absolute minimum age on dose 2 based on EIPB clarification"}